Cargando…

Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients

AIMS: A nationwide diabetic retinopathy (DR) screening program has been established in Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings and to examine whether non-adherence was correlated to DR progression. METHODS: The population consisted of a register-based coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Thykjær, Anne Suhr, Andersen, N., Bek, T., Heegaard, S., Hajari, J., Laugesen, C. S., Möller, S., Pedersen, F. N., Rosengaard, L., Schielke, K. C., Kawasaki, R., Højlund, K., Rubin, K. H., Stokholm, L., Grauslund, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519674/
https://www.ncbi.nlm.nih.gov/pubmed/35953626
http://dx.doi.org/10.1007/s00592-022-01946-4
_version_ 1784799452589981696
author Thykjær, Anne Suhr
Andersen, N.
Bek, T.
Heegaard, S.
Hajari, J.
Laugesen, C. S.
Möller, S.
Pedersen, F. N.
Rosengaard, L.
Schielke, K. C.
Kawasaki, R.
Højlund, K.
Rubin, K. H.
Stokholm, L.
Grauslund, J.
author_facet Thykjær, Anne Suhr
Andersen, N.
Bek, T.
Heegaard, S.
Hajari, J.
Laugesen, C. S.
Möller, S.
Pedersen, F. N.
Rosengaard, L.
Schielke, K. C.
Kawasaki, R.
Højlund, K.
Rubin, K. H.
Stokholm, L.
Grauslund, J.
author_sort Thykjær, Anne Suhr
collection PubMed
description AIMS: A nationwide diabetic retinopathy (DR) screening program has been established in Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings and to examine whether non-adherence was correlated to DR progression. METHODS: The population consisted of a register-based cohort, who participated in the screening program from 2013 to 2018. We analyzed age, gender, marital status, DR level (International Clinical DR severity scale, none, mild-, moderate-, severe non-proliferative DR (NPDR) and proliferative DR (PDR)), comorbidities and socioeconomic factors. The attendance pattern of patients was grouped as either timely (no delays > 33%), delayed (delays > 33%) or one-time attendance (unexplained). RESULTS: We included 205,970 patients with 591,136 screenings. Rates of timely, delayed and one-time attendance were 53.0%, 35.5% and 11.5%, respectively. DR level at baseline was associated with delays (mild-, moderate-, severe NPDR and PDR) and one-time attendance (moderate-, severe NPDR and PDR) with relative risk ratios (RRR) of 1.68, 2.27, 3.14, 2.44 and 1.18, 2.07, 1.26, respectively (P < 0.05). Delays at previous screenings were associated with progression to severe NPDR or PDR (hazard ratio (HR) 2.27, 6.25 and 12.84 for 1, 2 and 3+ delays, respectively). Any given delay doubled the risk of progression (HR 2.28). CONCLUSIONS: In a national cohort of 205,970 patients, almost half of the patients attended DR screening later than scheduled or dropped out after first screening episode. This was, in particular, true for patients with any levels of DR at baseline. DR progression in patients with delayed attendance, increased with the number of missed appointments.
format Online
Article
Text
id pubmed-9519674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-95196742022-09-30 Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients Thykjær, Anne Suhr Andersen, N. Bek, T. Heegaard, S. Hajari, J. Laugesen, C. S. Möller, S. Pedersen, F. N. Rosengaard, L. Schielke, K. C. Kawasaki, R. Højlund, K. Rubin, K. H. Stokholm, L. Grauslund, J. Acta Diabetol Original Article AIMS: A nationwide diabetic retinopathy (DR) screening program has been established in Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings and to examine whether non-adherence was correlated to DR progression. METHODS: The population consisted of a register-based cohort, who participated in the screening program from 2013 to 2018. We analyzed age, gender, marital status, DR level (International Clinical DR severity scale, none, mild-, moderate-, severe non-proliferative DR (NPDR) and proliferative DR (PDR)), comorbidities and socioeconomic factors. The attendance pattern of patients was grouped as either timely (no delays > 33%), delayed (delays > 33%) or one-time attendance (unexplained). RESULTS: We included 205,970 patients with 591,136 screenings. Rates of timely, delayed and one-time attendance were 53.0%, 35.5% and 11.5%, respectively. DR level at baseline was associated with delays (mild-, moderate-, severe NPDR and PDR) and one-time attendance (moderate-, severe NPDR and PDR) with relative risk ratios (RRR) of 1.68, 2.27, 3.14, 2.44 and 1.18, 2.07, 1.26, respectively (P < 0.05). Delays at previous screenings were associated with progression to severe NPDR or PDR (hazard ratio (HR) 2.27, 6.25 and 12.84 for 1, 2 and 3+ delays, respectively). Any given delay doubled the risk of progression (HR 2.28). CONCLUSIONS: In a national cohort of 205,970 patients, almost half of the patients attended DR screening later than scheduled or dropped out after first screening episode. This was, in particular, true for patients with any levels of DR at baseline. DR progression in patients with delayed attendance, increased with the number of missed appointments. Springer Milan 2022-08-12 2022 /pmc/articles/PMC9519674/ /pubmed/35953626 http://dx.doi.org/10.1007/s00592-022-01946-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Thykjær, Anne Suhr
Andersen, N.
Bek, T.
Heegaard, S.
Hajari, J.
Laugesen, C. S.
Möller, S.
Pedersen, F. N.
Rosengaard, L.
Schielke, K. C.
Kawasaki, R.
Højlund, K.
Rubin, K. H.
Stokholm, L.
Grauslund, J.
Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
title Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
title_full Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
title_fullStr Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
title_full_unstemmed Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
title_short Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
title_sort attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519674/
https://www.ncbi.nlm.nih.gov/pubmed/35953626
http://dx.doi.org/10.1007/s00592-022-01946-4
work_keys_str_mv AT thykjærannesuhr attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT andersenn attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT bekt attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT heegaards attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT hajarij attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT laugesencs attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT mollers attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT pedersenfn attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT rosengaardl attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT schielkekc attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT kawasakir attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT højlundk attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT rubinkh attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT stokholml attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients
AT grauslundj attendanceinanationalscreeningprogramfordiabeticretinopathyapopulationbasedstudyof205970patients